1. India Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
Arvaya Healthcare Ltd

Arvaya Healthcare Ltd

BBSE:ARVAYA
102.75
INR
+2.00
(+1.99%)
0.40EPS
216.87P/E
3.23BMarket Cap
Arvaya Healthcare Ltd
BSE:ARVAYA
(Bombay Stock Exchange)

Recent

price

102.75

P/E

ratio

216.87

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
INR
- -
- -
0.86
1.09
1.64
1.42
4.38
1.46
1.33
1.64
1.34
1.09
1
0.93
0.92
7.49
10.25
Revenue per Share
0.23
0.15
0.06
0.12
0.01
-0.18
-0.43
-0.38
-0.27
-0.18
-0.3
-0.63
-1.48
-0.39
0.45
0.7
0.31
Basic EPS, GAAP
- -
- -
-0.06
-0.34
0.55
-0.76
-1.76
-0.52
0.08
-0.27
-0.06
-1.23
-1.25
-0.98
0.72
-7.84
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
15.65
15.71
15.83
15.84
15.36
14.93
14.55
14.28
14.1
13.8
13.18
11.7
11.31
11.76
12.47
- -
Book Value per Share
- -
15.65
15.71
15.83
15.84
15.36
14.93
14.55
14.28
14.1
13.8
13.18
11.7
11.31
11.76
6.57
- -
Tangible Book Value per Share
3
3
3
3
2
3
3
3
3
3
3
3
3
3
3
10
38
Basic Weighted Avg Shares
- -
- -
3
3
4
4
13
4
4
5
4
3
3
3
3
76
390
Sales/Revenue/Turnover
- -
- -
-98.26
-68.71
-83.93
-75.2
-26.79
-81.17
-77.1
-57.26
-72.86
-103.32
-127.04
-147.81
-189.72
5.53
5.12
Operating Margin (%)
1
1
1
1
1
1
1
1
1
- -
- -
- -
1
- -
- -
6
28
Depreciation Expense
1
- -
- -
- -
- -
-1
-1
-1
-1
-1
-1
-2
-4
-1
1
7
12
Net Income, GAAP
15.64
12.7
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
28.65
17.38
12.45
Effective Tax Rate (%)
- -
- -
6.97
10.98
0.61
-12.67
-9.82
-25.87
-20.25
-10.95
-22.02
-57.67
-148.23
-41.88
49.44
9.35
3.02
Profit Margin (%)
- -
33
34
35
37
36
34
33
34
30
28
28
17
18
29
54
- -
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
- -
435
- -
LT Debt
- -
47
47
48
48
46
45
44
43
42
41
40
35
34
35
631
- -
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.22
0.18
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
4.05
1.44
- -
Return on Capital (%)
- -
- -
0.4
0.76
0.05
-1.15
-2.87
-2.56
-1.86
-1.27
-2.12
-4.65
-11.9
-3.4
3.93
2.24
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
59
- -
LT Borrowings
- -
80
- -
LT Finance Leases
- -
354
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
48
48
48
Market Capitalization
- -
- -
3,226

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
381
- -
Cash, Cash Equivalents & STI
- -
24
- -
Accounts Receivable, Net
- -
22
- -
Inventories
- -
19
- -
Total Current Liabilities
- -
327
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
59
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
166.2%
334.51%
1,687.67%
Free Cash Flow
-249.13%
-380.13%
-3,777.02%
Net Income, GAAP
51.07%
75.84%
420.94%
Sales/Revenue/Turnover
276.13%
523.95%
2,655.21%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1
1
1
- -
3
2026
- -
- -
- -
91
76
2027
299
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-0.17
-0.47
1.78
-0.68
0.45
2026
-0.34
-0.41
-0.03
0.26
0.7
2027
0.08
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
Arvaya Healthcare Ltd is an India-based healthcare and pharmaceutical enterprise engaged in the trading, distribution, and commercialization of pharmaceutical formulations, medical consumables, diagnostic supplies, and healthcare wellness products. The company operates across key business segments including Pharmaceuticals, Medical Consumables and Devices, Nutraceuticals, and Healthcare Supply Chain Services. Its comprehensive product and service portfolio comprises prescription pharmaceutical formulations, including generic antibiotics, analgesics, anti-inflammatory medications, oral solid dosage forms, capsules, syrups, and topical ointments; active pharmaceutical ingredients (APIs) and chemical intermediates for pharmaceutical manufacturing; medical devices and surgical consumables, such as disposable syringes, surgical gloves, IV infusion sets, wound care dressings, surgical sutures, and rapid diagnostic test kits; over-the-counter (OTC) healthcare products, including dietary supplements, vitamins, minerals, herbal extracts, and immunity boosters; and institutional procurement, warehousing, and healthcare logistics management services. Arvaya Healthcare serves a diversified client base consisting of government and private hospital networks, clinical laboratories, retail pharmacy chains, wholesale medical distributors, and outpatient healthcare centers across domestic Indian markets. In recent corporate developments, the company has undertaken strategic business restructuring and corporate rebranding to accelerate its expansion across high-growth healthcare segments. Over the past two years, Arvaya Healthcare has entered into strategic supply agreements with certified pharmaceutical manufacturers for third-party formulation production, introduced an expanded line of proprietary wellness and nutraceutical products, and broadened its regional logistics infrastructure to strengthen direct-to-institution medical supply operations. Headquartered in India and listed on the BSE under the ticker symbol ARVAYA, the company continues to scale its healthcare distribution network across urban and semi-urban markets.